NEW YORK (GenomeWeb) – Liquid biopsy firm CellMax Life said today that it has received an NT$23 million ($760,846) grant from the Taiwan Government Industrial Development Bureau Ministry of Economic Affairs. 

The company plans to use the funding to accelerate its efforts to automate its circulating tumor cell-based technology, and to advance plans for world-wide commercialization of its early cancer detection platform CMxTM.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.